Luigi Mansi – författare

This book covers all diagnostic and therapeutic aspects of neuro-oncological diseases. In the last decade, the management of brain tumors has been revolutionized following the new WHO classification and thanks to the introduction of molecular markers into the clinical routine. From an imaging point of view, the continuous technological developments and the implementation of various radiopharmaceuticals have paved the way to new clinical indications and has helped optimize patient management. In this context, a major breakthrough could derive from the introduction of radiomics and artificial intelligence in the diagnostic and therapeutic pathway. Not forgetting the emerging role of heavy-ion therapy as a complement to the innovative drugs and treatments adopted in medical oncology and radiation therapy.

In the present book, all above-mentioned aspects are covered, starting with the novel standards for the WHO classification of brain tumors, to the up-to-date surgical techniques and advanced therapeutic approaches, passing through the currently available imaging modalities and ongoing developments embracing both radiology and nuclear medicine discipline. Imaging represents indeed the “trait d''union” for all the arguments described in the book; therefore, in most chapters there are dedicated sessions focused on the role of imaging in each specific context.

The publication aims to fill the gap between the clinicians and all professionals directly involved in the management of patients with brain tumors and the newest scientific outreach. Moreover, thanks to the comprehensive insight into the latest technological developments, scientists and researchers interested in the topic will find the book a useful tool for future studies and perspective discoveries.

This essential book, amid the rapid shift toward hybrid imaging, empowers radiographers, technologists and practitioners to build on solid fundamentals, strengthen patient care, and refine advanced techniques.

Uniqueness: This book provides a comprehensive perspective on hybrid imaging and patient management, offering insights not only from physicians and radiographers but also from other key professionals, such as physicists, psychologists, and other interdisciplinary experts. Specifically tailored for radiographers—yet equally valuable for anyone seeking a deeper understanding of hybrid imaging technology and techniques—it fills a critical void in current educational resources.

Structured Approach: Organized into eighteen chapters, the book offers a clear, methodical framework that starts with foundational concepts to introduce the reader to the subject and builds progressively toward more advanced topics, including specialized skills and patient-centered imaging practices. It is an excellent reference for professionals at any stage of their career, from beginners to experts.

Target Audience: Designed for radiographers, students, residents, and practitioners exploring cutting-edge hybrid imaging technologies, this text bridges the gap between theoretical knowledge of instrumentation and its real-world application in both daily practice and patient care.

Filling a gap: By comprehensively covering both hybrid imaging and patient management from a radiographer’s perspective, this textbook serves as an indispensable educational resource. It equips readers with the knowledge and skills needed to meet the growing demand for expertise and advanced, patient-tailored imaging in this dynamic field.

This user-friendly atlas, featuring about 500 images, should be a quick guide to interpreting PET/CT images with FDG in oncology. It also illustrates how to recognize normal, para-physiological, and benign pathological uptakes in a case-based practical manner. The text, which includes most relevant technical and pathophysiological premises, covers the main clinical applications and clearly articulates learning points and pitfalls. This atlas aims to become a standard text for nuclear medicine physicians and radiologists, residents and technicians whose work involves PET/CT imaging. This book is also suitable for both undergraduate and postgraduate courses.

Although [18F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. Such non-FDG tracers are now gaining widespread acceptance not only in research but also in clinical practice. This atlas, including about 500 high-quality images, is a user-friendly guide to PET-CT imaging beyond FDG. A wide range of tracers is covered, such as 18F- and 11C-choline, 11C-methionine, 18F-ethyl-L-tyrosine, 68Ga-DOTA-NOC, 11C-acetate, 11C-thymidine, and 18F-DOPA. Throughout, the emphasis is on image interpretation, with guidance on the recognition of normal, benign, and malignant uptake and clear instruction on learning points and pitfalls. This atlas is designed to serve as a reference text for both nuclear physicians and radiologists, and will also be of great benefit to radiographers, technologists, and nuclear medicine and radiology residents.